|
Match
|
Document |
Document Title |
|
|
7479269 |
Methods for selectively enriching TH1 and TH2 cells
Methods for inducing a population of T cells to proliferate by activating the population of T cells and stimulating an accessory molecule on the surface of the T cells with a ligand which binds the...
|
|
|
7309501 |
Conditioned media to inhibit growth of tumor cells
Conditioned media compositions having valuable biological activity are obtained from cultures of immune cells from elasmobranch fishes. A method is provided for producing the conditioned media...
|
|
|
7232566 |
Methods for treating HIV infected subjects
Methods for inducing a population of T cells to proliferate by activating the population of T cells and stimulating an accessory molecule on the surface of the T cells with a ligand which binds the...
|
|
|
7195758 |
Methods of inducing a T cell mediated immune response by administering antigen presenting B cells
We teach a strategy to obtain large quantities of desired APCs, activated B cells, which are superior in their capacity to present tumor protein antigen in a multiadministration protocol. Human B...
|
|
|
7175843 |
Methods for selectively stimulating proliferation of T cells
Methods for inducing a population of T cells to proliferate by activating the population of T cells and stimulating an accessory molecule on the surface of the T cells with a ligand which binds the...
|
|
|
7144575 |
Methods for selectively stimulating proliferation of T cells
Methods for inducing a population of T cells to proliferate by activating the population of T cells and stimulating an accessory molecule on the surface of the T cells with a ligand which binds the...
|
|
|
6984383 |
Method of transplanting cells by contacting donor cells with B7-1-and B7-2-specific immunoglobulins
The invention relates to a humanized anti-B7-2 antibody that comprises a variable region of nonhuman origin and at least a portion of an immunoglobulin of human origin. The invention also pertains...
|
|
|
6733791 |
Sublingual compositions comprising thymosin fraction 5 and methods for administration thereof
Methods and compositions are described which allow for the sublingual absorption of peptides by oral administration. A liquid and a tablet format for the sublingual approach are demonstrated. The...
|
|
|
6673832 |
Methods for identifying compounds for treating pain
The invention provides a method of determining whether a compound alleviates vasoconstriction-independent nerve pain mediated by endothelin-1 (ET-1). The method involves (i) determining whether the...
|
|
|
6497876 |
Method of stimulating an immune response with activated dendritic cells
Antigen-expressing, activated dendritic cells are disclosed. Such dendritic cells are used to present tumor, viral or bacterial antigens to T cells, and can be useful in vaccination protocols....
|
|
|
6352694 |
Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
Methods for inducing a population of T cells to proliferate by activating the population of T cells and stimulating an accessory molecule on the surface of the T cells with a ligand which binds the...
|
|
|
6270756 |
Weight loss induced by alpha interferon and gamma interferon
The invention is based on the discovery that substances which release ZAG proteins from lymphocytes also cause accelerated weight loss in humans. By administering an amount of the substance which...
|
|
|
6239105 |
Homeopathic preparations of purified growth hormone
The present invention comprises homeopathic preparations of purified growth hormone, as well as methods and systems for delivery of such preparations and treatment of disorders and conditions by...
|
|
|
6221352 |
Method of preventing the proliferation of Vβ14 or Vβ17-Expressing T cells
The present invention provides vaccines and a means of vaccinating a vertebrate so as to prevent or control specific T cell mediated pathologies, including autoimmune diseases and the unregulated...
|
|
|
6187750 |
Method of hormone treatment for patients with symptoms consistent with multiple sclerosis
A method for treating patients having symptoms consistent with multiple sclerosis comprising administering a regimen of doses of human growth hormone of less than 0.5 mg/day. In one aspect, the...
|
|
|
6159470 |
Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations
The present invention provides vaccines and a means of vaccinating a mammal so as to prevent or control specific T cell mediated pathologies or to treat the unregulated replication of T cells. The...
|
|
|
6143292 |
Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
A method of treating a human cancer patient having a solid tumor comprising malignant cells is disclosed, wherein the patient having undergone a cancer therapy regimen comprising allogeneic stem...
|
|
|
5998370 |
Agents for the prevention and/or treatment of radiation-induced disorders by administrating TCF-II
The use of Tumor Cytotoxic Factor-II (TCF-II) enables the prevention and/or treatment of radiation-induced disorders.
|
|
|
5800539 |
Method of allogeneic hematopoietic stem cell transplantation without graft failure or graft vs. host disease
The present invention provides a method of transplanting hematopoietic system reconstituting cells from a donor into an allogeneic recipient comprising administering to the recipient, prior to the...
|
|
|
5698767 |
Human immune system in non-human animal
Laboratory non-human animals in which the immune system of a donor is induced in and thrives in vivo and expresses the immune response of the donor animal in a recipient non-human animal of a...
|
|
|
5643551 |
Small animal metastasis model
A method for initiating metastasis of human tumor cells under experimental conditions is provided. Immunocompromised non-human mammals having a viable, xenogeneic organ or tissue are used as a host...
|
|
|
5639939 |
Chimeric immunocompromised mammal comprosing vascularized fetal organ tissue
Xenogeneic tissue is introduced into an immunocompromised host for interacting with agents and using such interaction for evaluating efficacy of drugs and vaccines, producing xenogeneic monoclonal...
|
|
|
5633426 |
In vivo use of human bone marrow for investigation and production
Chimeric immunocompromised hosts are provided, comprising human bone marrow of at least 4 weeks from the time of implantation. The bone marrow is found to assume the normal population of bone...
|
|
|
5516977 |
Xenogeneic tissue implant in ear pinna
Immunocompromised hosts comprising xenogeneic fetal lymph node tissue implanted in the ear pinna are provided. The chimeric hosts are prepared by inserting the xenogeneic lymph node tissue into the...
|
|
|
5434341 |
Xenogeneic lymph node in mammary fat pad
Methods and chimeric immunocompromised hosts comprising functional xenogeneic organs are provided, particularly hematopoietic organs, where the xenogeneic organ is engrafted into a mammary fat pad....
|
|
|
5411749 |
Human lymphoid tissue in an immunocompromised host
Human lymphoid tissue is introduced into an immunocompromised host to provide opportunities to investigate the effect of stimuli on the human immune system and obtain information and products from...
|
|
|
5114722 |
Medicament from Peyer's patches
The invention relates to a medicament in the form of a lyophilisate produced from a total extract from Peyer's patches, preferably in homoeopathic dilution. It can be used advantageously for the...
|
|
|
5108760 |
Enhances LAK cell activation by treatment of human peripheral blood mononuclear cells with amino acid amides
There is provided an improved process for enhanced LAK cell activation wherein the peripheral blood mononuclear cells are treated with an amino acid amide to yield depletion, prior to the...
|
|
|
5041289 |
Method of purging residual tumor cells in vitro with lymphokine activated cytotoxic cells
A method is disclosed for removing residual tumor cells from a patient with a neoplastic disorder by treating in vitro cell preparation with lymphokine activated cytotoxic cells.
|
|
|
4749522 |
Supercritical fluid extraction of animal derived materials
Supercritical fluids (SCF) are found to be useful in extracting desired materials from animal tissues, cells, and organs. By varying the choice of SCF, experimental conditions, and animal source...
|
|
|
4705687 |
Treatment of autoimmune diseases such as rheumatoid arthritis with suppressor factor
Method of treating autoimmune diseases such as rheumatoid arthritis by administration of a suppressor factor obtained in the supernatant of a human cell line. A particular human cell line is CEM...
|
|
|
4594245 |
Augmenting factors for human antibody production and process for peparing the same
Augmenting factors for human antibody production having a molecular weight of 2,000-4,000 are prepared from the supernatant of cultured human lymphocytes. Nylon wool-adherent cells of human...
|
|
|
4377514 |
Method for producing factor for the stimulation of the liver cell proliferation rate
A process for making factor for stimulating the rate of proliferation of liver cells comprising homogenizing animal Peyer's glands, adjusting pH to about 5.5, thermally denaturing the product and...
|
|
|
3846544 |
SPARINGLY-SOLUBLE KALLIKREIN-INACTIVATOR DERIVATIVE AND PROCESSES INVOLVING SAID DERIVATIVE
A sparingly soluble derivative of kallikrein-inactivator and metaphosphoric acid or metaphosphoric acid salts are prepared. The method may also be used as part of a purification procedure for...
|
|
|
3300384 |
Process for the production of pure preparations of the kallikrein inactivator
|
|
|
3010874 |
Methods of preparation of proteolysate products
|
|
|
3558773 |
Title is not available
|